Reported Reactions

Devices › Programmer, pacemaker

Device brand name · Programmer pacemaker

Carelink Encore: medical device reports filed with FDA

368 reports name it, 2014–2019. Manufacturer given most often on reports: Plexus Manufacturing Sdn Bhd. Product code KRG.

368
device reports naming the brand
0% of all MAUDE reports · about 30 a year
0
reports, 12 months to August 2026
0 in the 12 months before
98.4%
classified as malfunction
96.7% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 368 reports that name the brand "Carelink Encore" (programmer pacemaker), received between June 2014 and May 2019; the manufacturer given most often on reports is Plexus Manufacturing Sdn Bhd. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.4%) and injury (1.6%); across all programmer, pacemaker reports (product code KRG) death is recorded in 0.1% and malfunction in 96.7%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are computer operating system problem (28.8%), power problem (28.8%) and computer software problem (18.5%). The patient problems coded most often are no patient involvement and syncope. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Carelink Encore was received in the five years to August 2026; the latest was received in May 2019.

By year received

050992014: 720142015: 8520152016: 6920162017: 7620172018: 9920182019: 322019

Event type and report source

Event type, as classified on the report

Death0%0
Injury1.6%6
Malfunction98.4%362
Other0%0
Not given0%0

Who filed the report

Manufacturer report99.7%367
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0.3%1

Grey bar: all 24,211 reports carrying product code KRG. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Computer operating system problem10628.8%8.3%
Power problem10628.8%2.9%
Computer software problema software problem6818.5%7.2%
No display/image5715.5%12.9%
Battery problema problem with the battery3810.3%0.5%
Failure to power up369.8%3.6%
Device difficult to program or calibrate318.4%14%
Unexpected shutdown246.5%3.1%
Failure to interrogate174.6%3.1%
Overheating of device174.6%2.6%
Communication or transmission problemthe device could not communicate or transmit133.5%9.1%
Inadequate user interface133.5%2.5%
Output problem113%6.6%
Connection problema connection problem82.2%2.9%
Failure to calibrate82.2%4.6%
Operating system becomes nonfunctional71.9%1.5%
Problem with software installation71.9%2%
Mechanical problema mechanical problem61.6%4%
Data problem51.4%1.4%
Failure to shut off41.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
No patient involvement14940.5%
Syncopefainting10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCarelink EncoreProduct code KRGAll MAUDE reports
Reports36824,21126,136,888
Share of that pool—1.5%0%
Classified as death, per 1,000 reports019
Classified as injury1.6%3.2%36.2%
Classified as malfunction98.4%96.7%62.3%
Filed by the manufacturer99.7%99.9%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code KRG

BrandReportsLatest 12 monthsClassified as death
Carelink15,005180%
Carelink Programmer6,2645460%
CareLink Encore Programmer1,3431030%
Pacing System Analyzer607920%
SmartTouch6681320%
Orchestra71300.1%
Merlin Programmer1,425260.1%
Vitality 24,77901%
Medtronic Carelink Programmer With Analyzer173310%
Vitality2,09500.9%
Zoom44130%
N'vision26900.7%
Vitality Avt1,23502.3%
Carelink System34300.3%
Carelink Program W/Telemetry C1,68100%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Carelink Encore reports

How many FDA reports name Carelink Encore?

368 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (98.4%) and injury (1.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

computer operating system problem (28.8%), power problem (28.8%), computer software problem (18.5%), no display/image (15.5%) and battery problem (10.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Carelink Encore was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.